Epidemiology and Burden of Neurological Diseases in Developing Countries

Neurological diseases pose a significant burden in developing countries, encompassing clinical, economic, and humanistic aspects. This burden is influenced by various factors, including limited healthcare infrastructure, scarce resources, inadequate access to specialized care, and social disparities. The prevalence of neurological diseases in developing countries is substantial, with conditions such as stroke, epilepsy, neuroinfections, and neurodegenerative disorders being particularly prevalent. The clinical burden includes challenges in diagnosis, treatment, and long-term management, resulting in increased morbidity and complications. Economically, neurological diseases impose a heavy burden on individuals, families, healthcare systems, and economies, encompassing direct healthcare costs, indirect costs related to productivity loss, and financial hardships for patients and caregivers. The humanistic burden encompasses the impact on quality of life, mental health, social relationships, and overall well-being. Individuals and families face challenges in education, employment, social inclusion, and maintaining personal relationships. Addressing the burden of neurological diseases in developing countries requires comprehensive strategies, including strengthening healthcare infrastructure, improving access to care, promoting preventive measures, enhancing rehabilitation services, and fostering international collaborations. Moreover, strategies addressing the economic and humanistic burdens include supporting caregivers, reducing stigma, enhancing mental health support, and promoting inclusive policies. By implementing these strategies, it is possible to mitigate the burden of neurological diseases, improve outcomes, and enhance the overall well-being of individuals and communities affected by these conditions.